10X genomics, INC.:1279204 [25-000881]

Ended Awarded Last action

Contract number
75N92B25F00001
Awardee
Awarding agency
Obligated
$24,750

Award facts

Contract value 100% obligated
$24,750.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Pleasanton, CA 94588, USA

Award details come from SAM.gov/FPDS.

About this award

The National Institute of Arthritis and Musculoskeletal and Skin Diseases issued a BPA call to 10X Genomics, Inc. valued at $24,750.00 with an award date of April 13, 2022. The call was issued under a blanket purchase agreement and carries a firm fixed price structure with a completion date of January 31, 2025. Performance occurs in Pleasanton, California. No set-aside applies to this call.

Quick answers

Who was awarded contract 75N92B25F00001?

75N92B25F00001 was awarded to 10X Genomics, Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on April 13, 2022.

How much is contract 75N92B25F00001 worth?

The government has obligated $24,750 on 75N92B25F00001.

Is contract 75N92B25F00001 an order under another contract?

Yes. 75N92B25F00001 is a BPA call under 75N98022A00032, a blanket purchase agreement.

Was contract 75N92B25F00001 competed?

The extent of competition for 75N92B25F00001 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award